Crypto Market Ticker
Loading...

Pharma

HPM to Host Complimentary Webinar on Medical Device Update Year in Review

خلاصہ: HPM to Host Complimentary Webinar on Medical Device Update Year in ReviewHPM to Host Complimentary Webinar on Medical Device Update Year in Review Anonymous (not verified) Wed, 11/19/2025 - 00:39 pharmagather item url HPM to Host Complimentary Webinar on Medical Device Update Year in Review pharmagather item source FDA Law Blog pharmagather item publication date Wed, 11/19/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

November 18 2025 – Merck advances Winrevair in subset of heart failure patients

خلاصہ: November 18 2025 - Merck advances Winrevair in subset of heart failure patientsNovember 18 2025 - Merck advances Winrevair in subset of heart failure patients admin Tue, 11/18/2025 - 11:57 Merck advances Winrevair in subset of heart failure patientsMerck boardVanda tackles Wegovy-driven vomiting, sparking race to phase 3Vanda boardMedtronic lifts forecasts as heart and diabetes devices sell stronglyMedtronic boardRoche extols 'unprecedented' result with breast cancer drugRoche board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act  image Source InformationPublisher: Cafe PharmaOriginal Source: Read more

November 17 2025 – J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash

خلاصہ: November 17 2025 - J&J, aiming for $50b in cancer sales, buys Halda for $3b in cashNovember 17 2025 - J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash admin Mon, 11/17/2025 - 11:29 J&J, aiming for $50b in cancer sales, buys Halda for $3b in cashJNJ boardNovo Nordisk slashes out-of-pocket prices for Wegovy and OzempicNovo Nordisk boardLilly bets more than $2.6B for South Korea biotech’s bispecific antibody platformEli Lilly boardBMS, J&J give up on milvexian for acute coronary syndromeBristol Myers Squibb board, JNJ board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act  image Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Pharma Is Pushing Experience Out the Door — And the Consequences Are Already Here

خلاصہ: Pharma Is Pushing Experience Out the Door — And the Consequences Are Already HerePharma Is Pushing Experience Out the Door — And the Consequences Are Already Here Anonymous (not verified) Sat, 11/15/2025 - 15:34 pharmagather item url Pharma Is Pushing Experience Out the Door — And the Consequences Are Already He… pharmagather item source World of DTC Marketing pharmagather item publication date Sat, 11/15/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Huge Channels or No Channels: You Pick

خلاصہ: Huge Channels or No Channels: You PickHuge Channels or No Channels: You Pick Anonymous (not verified) Fri, 11/14/2025 - 15:33 pharmagather item url Huge Channels or No Channels: You Pick pharmagather item source In The Pipeline Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Is Pharma Testing Regulatory Limits with FDA Changes?

خلاصہ: Is Pharma Testing Regulatory Limits with FDA Changes?Is Pharma Testing Regulatory Limits with FDA Changes? Anonymous (not verified) Fri, 11/14/2025 - 15:33 pharmagather item url Is Pharma Testing Regulatory Limits with FDA Changes? pharmagather item source World of DTC Marketing pharmagather item publication date Fri, 11/14/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Trump’s consumer-driven healthcare is an irresponsibly destructive idea

خلاصہ: Trump’s consumer-driven healthcare is an irresponsibly destructive ideaTrump’s consumer-driven healthcare is an irresponsibly destructive idea Anonymous (not verified) Fri, 11/14/2025 - 03:31 pharmagather item url Trump’s consumer-driven healthcare is an irresponsibly destructive idea pharmagather item source World of DTC Marketing pharmagather item publication date Thu, 11/13/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Biochemical Tungsten – Really

خلاصہ: Biochemical Tungsten - ReallyBiochemical Tungsten - Really Anonymous (not verified) Thu, 11/13/2025 - 15:31 pharmagather item url Biochemical Tungsten - Really pharmagather item source In The Pipeline Source InformationPublisher: Cafe PharmaOriginal Source: Read more

The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal

خلاصہ: The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the CoalThe GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal Anonymous (not verified) Thu, 11/13/2025 - 12:31 pharmagather item url The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal pharmagather item source World of DTC Marketing pharmagather item publication date Thu, 11/13/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

November 13 2025 – Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings

خلاصہ: November 13 2025 - Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filingsNovember 13 2025 - Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings admin Thu, 11/13/2025 - 11:37 Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filingsGilead Sciences boardMetsera shareholders vote for up to $10 billion acquisition by PfizerPfizer boardNovo Nordisk faces rare shareholder rebuke over board shake-upNovo Nordisk boardFDA unveils new regulatory roadmap for bespoke drug therapiesPharma/Biotech General Discussion board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act  image Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Medicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses

خلاصہ: Medicare Part D 2026: Preferred Networks Vanish as the PDP Market CollapsesMedicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses Anonymous (not verified) Thu, 11/13/2025 - 09:31 pharmagather item url Medicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses pharmagather item source Drug Channels pharmagather item publication date Thu, 11/13/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle?

خلاصہ: Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle?Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle? Anonymous (not verified) Thu, 11/13/2025 - 00:31 pharmagather item url Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype … pharmagather item source World of DTC Marketing pharmagather item publication date Wed, 11/12/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and More

خلاصہ: Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and MoreDrug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and More Anonymous (not verified) Wed, 11/12/2025 - 09:29 pharmagather item url Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Par… pharmagather item source Drug Channels pharmagather item publication date Wed, 11/12/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

GLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities

خلاصہ: GLP-1s: A Weight Loss Revolution Comes With Challenges & OpportunitiesGLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities Anonymous (not verified) Wed, 11/12/2025 - 12:29 pharmagather item url GLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities pharmagather item source World of DTC Marketing pharmagather item publication date Wed, 11/12/2025 - 12:00 Source InformationPublisher: Cafe PharmaOriginal Source: Read more

November 12 2025 – Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out

خلاصہ: November 12 2025 - Bayer bails on Vividion tumor drug as part of early-stage cancer clear-outNovember 12 2025 - Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out admin Wed, 11/12/2025 - 11:44 Bayer bails on Vividion tumor drug as part of early-stage cancer clear-outBayer boardMedtech VC funding slows in Q3: PitchBookMedtech General Discussion boardAlkermes breaks new ground in narcolepsy with orexin drugAlkermes boardFDA names longtime oncology chief Richard Pazdur as its new CDER directorPharma/Biotech General Discussion board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act  image Source InformationPublisher: Cafe PharmaOriginal Source: Read more

Recent Articles